Next edition in

The intelligence layer
for what's reshaping markets.

Verified signals from 100+ curated sources — delivered to your inbox twice daily as a 3-minute read.

Free during early access · No spam, unsubscribe anytime · Tracking tickers across active themes

Check your email to confirm your subscription.

Signal
Verify
Connect
Move
This is today's live edition
JULY 15, 2026 Evening Edition 4 stories
No stories match your search.
Earnings

ASML Raises 2026 Revenue Forecast on AI Chip Demand, Plans Capacity Expansion

ASML raised its full-year 2026 net revenue guidance to €43–45 billion ($49–51 billion), up from a prior range of €36–40 billion, after reporting Q2 2026 revenue of €9.33 billion and net income of €2.92 billion, both ahead of analyst estimates. The Dutch lithography equipment maker also announced plans to expand EUV and DUV manufacturing capacity by 30% in 2027 and 2028, citing accelerating demand from AI chip producers. ASML shares rose 3.7% to €1,613 on the news, bringing year-to-date gains to approximately 75%. Chinese customers are expected to account for roughly 20% of 2026 sales.

Regulation

Japan Designates Cryptocurrency as Financial Assets Under New Law

Japan's parliament passed a law amendment on July 15, 2026, formally designating cryptocurrencies as financial assets, moving them out of the Payment Services Act framework and into a different regulatory regime. The change introduces insider trading rules and harsher penalties for unregistered trading activity. The legislation is expected to take effect within one year, with the overhaul intended to address the growing user bases of domestic crypto exchanges.

Startup Funding

OpenAI Researcher Miles Wang in Talks to Launch $2B AI Drug Discovery Startup

OpenAI researcher Miles Wang is in talks to raise approximately $200 million at a $2 billion valuation for a new AI drug discovery startup, with Lightspeed in discussions to lead the round, according to TechCrunch (July 14, 2026). Wang, who joined OpenAI in 2024 after leaving Harvard, is expected to be joined by several other OpenAI researchers. The fundraise comes on the same day Chai Discovery announced a $400 million raise at a $3.8 billion valuation, and follows Isomorphic Labs' $2.1 billion Series B closed in May 2026, underscoring sustained investor appetite for AI-enabled drug discovery platforms.

Research

Agentic RL and Manipulation Research Accelerating Across AI and Robotics Labs

An analysis of 1,259 ArXiv papers published over a single seven-day period reveals a concentrated surge in research at the intersection of artificial intelligence and robotics: 44 papers on AI agents, 33 on reinforcement learning, 46 on robotic manipulation, and 13 on humanoid systems appeared simultaneously, with shared topics such as sim-to-real transfer and foundation models bridging both domains. The parallel output across AI/ML (533 papers total) and robotics (508 papers total) suggests the two fields are converging around a common technical stack, with implications for companies developing both software agents and physical hardware platforms.

Articles
Tickers tracked
Active themes
100+
Sources

What readers are saying

Don't miss the next edition

Verified signals, delivered twice daily as a 3-minute read. Next edition: .

The Fourth Factor provides news and analysis for informational purposes only. Nothing published here constitutes financial advice. Always consult a qualified financial advisor before making investment decisions.